13F-HR filed by Alerce Investment Management, L.P.
Alerce Investment Management, L.P. filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 7 holding rows worth $146,099,000.
- Accession
- 0001844002-21-000005
- Filer
- CIK 1844002
- Filed
- 2021-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 7 entries on the cover page, a total value of $146,099,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $146,099,000 with VALUE read as thousands by filing date, 13F file number 028-20675. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AMERICAN WELL CORP | 03044L105 | CL A | 6,300,773 | $57,400,000 | thousands by filing date | |
| ANNEXON INC | 03589W102 | COM | 1,954,978 | $36,382,000 | thousands by filing date | |
| AILERON THERAPEUTICS INC COM NEW | 00887A105 | Stock | 16,609,449 | $16,942,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 4,652,561 | $13,399,000 | thousands by filing date | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 374,785 | $11,007,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 2,227,500 | $7,752,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 126,270 | $3,217,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001844002-21-000005 | this filing | 2021-11-15 | acceptance time not in the bulk data set |